Hanmi Pharmaceutical's 'Gugutams' will be launched in Mexico as 'Aditams', marking the beginning of a full-scale expansion into Latin America
Hanmi Pharmaceutical's combination therapy for Obstructive Prostatic Growth (OPG) caused by Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED), Gugutams, is entering the Mexican market under the local brand name "Aditams."